Nrf2 Activator PB125 as a Potential Therapeutic Agent Against COVID-19
J. M. McCord, B. M. Hybertson, A. Cota-Gomez, B. Gao
The paper investigates how PB125, an Nrf2 activator, reduces ACE2 and TMPRSS2 expression and cytokine production in cells, potentially mitigating COVID-19 severity.
bioRxiv · May 16, 2020Cell Biology